Your browser doesn't support javascript.
loading
Interleukin-19 is a negative regulator of innate immunity and critical for colonic protection.
Azuma, Yasu-Taka; Matsuo, Yukiko; Nakajima, Hidemitsu; Yancopoulos, George D; Valenzuela, David M; Murphy, Andrew J; Karow, Margaret; Takeuchi, Tadayoshi.
Affiliation
  • Azuma YT; Laboratory of Veterinary Pharmacology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science, Izumisano, Osaka 598-8531, Japan. azuma@vet.osakafu-u.ac.jp
J Pharmacol Sci ; 115(2): 105-11, 2011.
Article in En | MEDLINE | ID: mdl-21157117
The cytokine, interleukin (IL)-19, is a member of the IL-10 family that includes IL-20, IL-22, IL-24, and IL-26. Recent studies have shown that IL-19 is produced by keratinocytes, epithelial cells, macrophages, and B-cells. Little is known about the exact biological role of IL-19 in immunological regulation, although there is an increasing body of data demonstrating that IL-19 is associated with the development of Th2 responses and the pathogenesis of psoriasis. In this review, I shall attempt to discuss current knowledge about the role of IL-19 on macrophages and the potential role in inflammatory bowel disease.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Interleukins / Colon / Immunity, Innate / Immunologic Factors / Macrophages Limits: Animals / Humans Language: En Journal: J Pharmacol Sci Journal subject: FARMACOLOGIA Year: 2011 Document type: Article Affiliation country: Japan Country of publication: Japan
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Interleukins / Colon / Immunity, Innate / Immunologic Factors / Macrophages Limits: Animals / Humans Language: En Journal: J Pharmacol Sci Journal subject: FARMACOLOGIA Year: 2011 Document type: Article Affiliation country: Japan Country of publication: Japan